FBLG insider trading
NasdaqCM HealthcareFibroBiologics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About FibroBiologics, Inc.
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Company website: fibrobiologics.com
FBLG insider activity at a glance
FilingIQ has scored 16 insider transactions for FBLG since Aug 12, 2024. The most recent filing in our index is dated May 4, 2026.
Across the full history, 10 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on FBLG insider trades is 62.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for FBLG?
- FilingIQ tracks 16 Form 4 insider transactions for FBLG (FibroBiologics, Inc.), covering filings from Aug 12, 2024 onwards. 10 of those were filed in the last 90 days.
- Are FBLG insiders net buyers or net sellers?
- Across the full Form 4 history for FBLG, 10 transactions (63%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does FBLG insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is FBLG in?
- FibroBiologics, Inc. (FBLG) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $22.47M.
Methodology & sources
Every FBLG insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.